Cyr61 inhibitors target and modulate the activity of the Cyr61 protein. Cyr61, also known as CCN1, belongs to the CCN (Cyr61/CTGF/Nov) family of matricellular proteins, which are secreted into the extracellular matrix and play multifaceted roles in cellular functions and tissue remodeling. Cyr61 is involved in diverse cellular processes, and its functions are mediated through interactions with various cell surface receptors, such as integrins and heparan sulfate proteoglycans. Upon binding to these receptors, Cyr61 triggers intracellular signaling pathways that modulate cellular responses to extracellular cues. It is an essential regulator of processes like cell adhesion, migration, proliferation, and survival. Additionally, Cyr61 plays a pivotal role in angiogenesis, the formation of new blood vessels from pre-existing ones, which is crucial for tissue growth and repair. Cyr61 inhibitors are specifically designed to disrupt the interactions between Cyr61 and its cellular receptors, disrupting the transmission of intracellular signals that would typically be initiated by Cyr61 binding. By doing so, these inhibitors can interfere with downstream gene expression and cellular responses that are influenced by Cyr61's activities.
The chemical structures of Cyr61 inhibitors may vary significantly, as researchers continually refine and optimize these compounds to enhance their selectivity and efficacy in modulating Cyr61's functions. The exact mechanisms by which Cyr61 inhibitors interact with Cyr61 and inhibit its activity can also differ based on their specific molecular properties. The targeted modulation of Cyr61 activity by these inhibitors has proven to be an invaluable tool in basic research. By using Cyr61 inhibitors, scientists can delve into the intricate regulatory networks that govern various cellular processes, shedding light on the significance of Cyr61 in normal physiological functions. Cyr61 inhibitors represent a specialized chemical class of compounds designed to selectively target Cyr61 and disrupt its interactions with cellular receptors. Through this targeted modulation, these inhibitors offer valuable tools for researchers to investigate the multifaceted roles of Cyr61 in cellular processes, tissue homeostasis, and angiogenesis, contributing to the advancement of knowledge in various fields of cellular biology.
VEJA TAMBÉM
Nome do Produto | CAS # | Numero de Catalogo | Quantidade | Preco | Uso e aplicacao | NOTAS |
---|---|---|---|---|---|---|
NSC 632839 hydrochloride | 157654-67-6 | sc-204138 sc-204138A | 10 mg 50 mg | $119.00 $465.00 | ||
Inibe a expressão de COL2A1 e a síntese de colagénio tipo II, reduzindo a degradação da cartilagem e a remodelação da matriz extracelular em doenças articulares como a osteoartrite. | ||||||
SB-3CT | 292605-14-2 | sc-205847 sc-205847A | 1 mg 5 mg | $100.00 $380.00 | 15 | |
Inibe a transcrição do gene COL2A1 e a ativação da MMP-2/9, atenuando a degradação da cartilagem e os processos inflamatórios associados à osteoartrite. | ||||||
Celastrol, Celastrus scandens | 34157-83-0 | sc-202534 | 10 mg | $155.00 | 6 | |
Reduz a expressão da COL2A1 e das citocinas pró-inflamatórias, atenuando a destruição da cartilagem na artrite graças às suas propriedades anti-inflamatórias. | ||||||
Chondroitinase ABC from Proteus vulgaris | 9024-13-9 | sc-507341 | 2 U | $650.00 | ||
Declara as cadeias de glicosaminoglicanos no aggrecan, modulando a renovação do COL2A1 e a remodelação da matriz nos processos de reparação da cartilagem. | ||||||
Heat Shock Protein Inhibitor I | 218924-25-5 | sc-221709 | 5 mg | $95.00 | 5 | |
Inibe indiretamente a Hsp70, reduzindo a expressão de COL2A1 e proporcionando potencialmente benefícios terapêuticos na artrite e noutras doenças relacionadas com o colagénio. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $182.00 $693.00 | 88 | |
Bloqueia as proteínas quinases associadas à Rho (ROCK), regulando potencialmente a síntese de COL2A1 e melhorando a fibrose e as doenças da cartilagem. | ||||||
KN-93 | 139298-40-1 | sc-202199 | 1 mg | $178.00 | 25 | |
Inibe a proteína quinase II dependente de Ca2+/calmodulina (CaMKII), atenuando a expressão de COL2A1 e as vias relacionadas com o colagénio dependentes de cálcio. | ||||||
Piperine | 94-62-2 | sc-205809 sc-205809A | 5 g 25 g | $36.00 $143.00 | 3 | |
Reduz a regulação da COL2A1 e das citocinas inflamatórias, atenuando potencialmente a degradação da cartilagem na artrite através das suas propriedades anti-inflamatórias. |